Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| TWG | Top Wealth Group | $18.38 | $12.37 | 205.82% | 480.7K | $3.7M | $4.25$28.11 |
| WVE | Wave Life Sciences | $18.58 | $11.09 | 148.06% | 132.3M | $1.3B | $5.28$19.60 |
| CETX | Cemtrex | $7.23 | $4.16 | 135.41% | 124.8M | $2.1M | $2.50$57.75 |
| WBUY | Webuy Global | $4.19 | $2.22 | 112.60% | 15M | $3.8M | $1.30$49.00 |
| GPCR | Structure Therapeutics | $70.03 | $35.47 | 102.62% | 696.8K | $2.1B | $13.22$94.90 |
| CMCT | Creative Media & Community Trust | $7.16 | $3.30 | 85.50% | 5M | $3.0M | $2.56$73.68 |
| FULC | Fulcrum Therapeutics | $14.11 | $5.21 | 58.48% | 20.8M | $481.7M | $2.32$15.74 |
| BDRX | Biodexa Pharmaceuticals Plc | $7.66 | $2.62 | 51.98% | 13M | $3.1M | $3.58$92.00 |
| KYMR | Kymera Therapeutics | $95.43 | $28.81 | 43.24% | 6.6M | $4.8B | $19.45$103.00 |
| TERN | Terns Pharmaceuticals | $41.20 | $11.84 | 40.34% | 7.5M | $2.6B | $1.87$45.00 |
Related Articles
Featured Article
Should You Invest in This Under-the-Radar Weight Loss Stock?
Prosper Junior Bakiny|Nov 30, 2025
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon?
Could This Be the Most Overlooked Way to Profit From the Artificial Intelligence Software Boom?
Harsh Chauhan|Nov 9, 2025
Investors should consider taking a closer look at this name before it steps on the gas.
1 Super Stock Down 76% You'll Wish You'd Bought on the Dip
Anthony Di Pizio|Oct 31, 2025
Data streaming is the key to turning generic artificial intelligence models into powerful tools for businesses and their customers.
Advertisement
2 Under-the-Radar Stocks That Could Soar
Prosper Junior Bakiny|Sep 21, 2025
They could ride the wave of the hottest therapeutic area in the industry.
This Under-the-Radar Healthcare Stock Could Soar in 2026
Prosper Junior Bakiny|Sep 12, 2025
We should know a lot more by year-end.
This AI Stock Just Hit a 52-Week Low -- Here's Why That's an Opportunity
Harsh Chauhan|Aug 10, 2025
This cloud specialist fell big time following its latest quarterly report, but it can regain its mojo in the long run.
1 Super Stock Down 81% to Buy Hand Over Fist, According to Wall Street
Anthony Di Pizio|Aug 7, 2025
Confluent stock plummeted after its recent earnings release, but Wall Street remains bullish.
